You are posting maliciously false information about DCVax-L. The actual quote you think gives you a get of jail card was
"But the problem there is the autologous dendritic cells are hard to get patented... So, the patents really are process patents and we could file one that tweaks things a little bit, and that's essentially that's what Northwest Bio did. They filed multiple patents just on little tweaks of the cocktails that are used to make the cells"
You are confusing IP strategy with therapeutic equivalence, in my view on purpose. You post on a global holiday a set of narrative disinformation and outright falsehoods to further denigrate the investigator, the academic institution, and the company.
Be very thoughtful how long you go on this road for..
Market Data 
Markets 
AI
